Literature DB >> 17663607

Patients' competence in and performance of cognitive therapy skills: relation to the reduction of relapse risk following treatment for depression.

Daniel R Strunk1, Robert J DeRubeis, Angela W Chiu, Jennifer Alvarez.   

Abstract

Cognitive therapy (CT) for depression is designed to teach patients material that is believed to help prevent relapse following successful treatment. This study of 35 moderately to severely depressed patients who responded to CT provides the 1st evidence to suggest that both development and independent use of these competencies predict reduced risk for relapse. Among patients who responded to treatment, both CT coping skills and in-session evidence of the independent implementation of CT material predicted lower risk for relapse in the year following treatment. These relationships were not accounted for by either symptom severity at the end of treatment or symptom change from pre- to posttreatment. Self-esteem, assessed at posttreatment, failed to predict risk for relapse in the year following treatment. Thus, CT coping skills and independent use of CT principles, but not overall satisfaction with oneself, appear to play an important role in relapse prevention.

Entities:  

Mesh:

Year:  2007        PMID: 17663607     DOI: 10.1037/0022-006X.75.4.523

Source DB:  PubMed          Journal:  J Consult Clin Psychol        ISSN: 0022-006X


  36 in total

1.  Mechanisms of change in cognitive therapy for major depressive disorder in the community mental health setting.

Authors:  Paul Crits-Christoph; Robert Gallop; Caroline K Diehl; Seohyun Yin; Mary Beth Connolly Gibbons
Journal:  J Consult Clin Psychol       Date:  2017-04-13

2.  Differential role of CBT skills, DBT skills and psychological flexibility in predicting depressive versus anxiety symptom improvement.

Authors:  Christian A Webb; Courtney Beard; Sarah J Kertz; Kean J Hsu; Thröstur Björgvinsson
Journal:  Behav Res Ther       Date:  2016-03-30

3.  Quality of coping skills predicts depressive symptom reactivity over repeated stressors.

Authors:  Abby D Adler; Laren R Conklin; Daniel R Strunk
Journal:  J Clin Psychol       Date:  2013-06-25

Review 4.  Cognitive behavioral therapy for mood disorders: efficacy, moderators and mediators.

Authors:  Ellen Driessen; Steven D Hollon
Journal:  Psychiatr Clin North Am       Date:  2010-09

5.  Assessing Patients' Cognitive Therapy Skills: Initial Evaluation of the Competencies of Cognitive Therapy Scale.

Authors:  Daniel R Strunk; Shannon N Hollars; Abby D Adler; Lizabeth A Goldstein; Justin D Braun
Journal:  Cognit Ther Res       Date:  2014-10

6.  Outcomes, skill acquisition, and the alliance: Similarities and differences between clinical trial and student therapists.

Authors:  Lizabeth A Goldstein; Abby D Adler Mandel; Robert J DeRubeis; Daniel R Strunk
Journal:  Behav Res Ther       Date:  2020-03-24

Review 7.  Serotonergic function, two-mode models of self-regulation, and vulnerability to depression: what depression has in common with impulsive aggression.

Authors:  Charles S Carver; Sheri L Johnson; Jutta Joormann
Journal:  Psychol Bull       Date:  2008-11       Impact factor: 17.737

8.  Computer-Assisted Cognitive Behavior Therapy to Prevent Relapse Following Electroconvulsive Therapy.

Authors:  Samuel T Wilkinson; Robert B Ostroff; Gerard Sanacora
Journal:  J ECT       Date:  2017-03       Impact factor: 3.635

9.  Cognitive Therapy Skills Predict Cognitive Reactivity to Sad Mood Following Cognitive Therapy for Depression.

Authors:  Daniel R Strunk; Abby D Adler; Shannon N Hollars
Journal:  Cognit Ther Res       Date:  2013-12

10.  Positive coping styles and perigenual ACC volume: two related mechanisms for conferring resilience?

Authors:  Nathalie E Holz; Regina Boecker; Christine Jennen-Steinmetz; Arlette F Buchmann; Dorothea Blomeyer; Sarah Baumeister; Michael M Plichta; Günter Esser; Martin Schmidt; Andreas Meyer-Lindenberg; Tobias Banaschewski; Daniel Brandeis; Manfred Laucht
Journal:  Soc Cogn Affect Neurosci       Date:  2016-01-07       Impact factor: 3.436

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.